These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21177797)

  • 1. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.
    Steinberg FM; Murray MJ; Lewis RD; Cramer MA; Amato P; Young RL; Barnes S; Konzelmann KL; Fischer JG; Ellis KJ; Shypailo RJ; Fraley JK; Smith EO; Wong WW
    Am J Clin Nutr; 2011 Feb; 93(2):356-67. PubMed ID: 21177797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial.
    Wong WW; Lewis RD; Steinberg FM; Murray MJ; Cramer MA; Amato P; Young RL; Barnes S; Ellis KJ; Shypailo RJ; Fraley JK; Konzelmann KL; Fischer JG; Smith EO
    Am J Clin Nutr; 2009 Nov; 90(5):1433-9. PubMed ID: 19759166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of soy isoflavone supplementation on nitric oxide metabolism and blood pressure in menopausal women.
    Wong WW; Taylor AA; Smith EO; Barnes S; Hachey DL
    Am J Clin Nutr; 2012 Jun; 95(6):1487-94. PubMed ID: 22552034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study.
    Brink E; Coxam V; Robins S; Wahala K; Cassidy A; Branca F;
    Am J Clin Nutr; 2008 Mar; 87(3):761-70. PubMed ID: 18326616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women.
    Teede HJ; Dalais FS; McGrath BP
    Am J Clin Nutr; 2004 Mar; 79(3):396-401. PubMed ID: 14985213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of soy isoflavone supplementation on menopausal quality of life.
    Amato P; Young RL; Steinberg FM; Murray MJ; Lewis RD; Cramer MA; Barnes S; Ellis KJ; Shypailo RJ; Fraley JK; Konzelmann KL; Fischer JG; LaSalle C; Smith EO; Wong WW
    Menopause; 2013 Apr; 20(4):443-7. PubMed ID: 23211877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.
    Levis S; Strickman-Stein N; Ganjei-Azar P; Xu P; Doerge DR; Krischer J
    Arch Intern Med; 2011 Aug; 171(15):1363-9. PubMed ID: 21824950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.
    Quaas AM; Kono N; Mack WJ; Hodis HN; Felix JC; Paulson RJ; Shoupe D
    Menopause; 2013 Aug; 20(8):840-4. PubMed ID: 23422867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
    Levis S; Strickman-Stein N; Doerge DR; Krischer J
    Contemp Clin Trials; 2010 Jul; 31(4):293-302. PubMed ID: 20230914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women.
    Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
    Nutrition; 2008 Feb; 24(2):120-6. PubMed ID: 18065202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: a randomized clinical trial.
    Chilibeck PD; Vatanparast H; Pierson R; Case A; Olatunbosun O; Whiting SJ; Beck TJ; Pahwa P; Biem HJ
    J Bone Miner Res; 2013 Apr; 28(4):780-93. PubMed ID: 23165609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
    Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of whole soy and purified daidzein on androgenic hormones in chinese equol-producing post-menopausal women: a six-month randomised, double-blinded and Placebo-Controlled trial.
    Liu ZM; Li G; Zhang D; Ho SC; Chen YM; Ma J; Huang Q; Li S; Ling WH
    Int J Food Sci Nutr; 2020 Aug; 71(5):644-652. PubMed ID: 31914834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.
    Alekel DL; Van Loan MD; Koehler KJ; Hanson LN; Stewart JW; Hanson KB; Kurzer MS; Peterson CT
    Am J Clin Nutr; 2010 Jan; 91(1):218-30. PubMed ID: 19906801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.
    Hazim S; Curtis PJ; Schär MY; Ostertag LM; Kay CD; Minihane AM; Cassidy A
    Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflavone supplementation in postmenopausal women does not affect leukocyte LDL receptor and scavenger receptor CD36 expression: A double-blind, randomized, placebo-controlled trial.
    Engelbert AK; Soukup ST; Roth A; Hoffmann N; Graf D; Watzl B; Kulling SE; Bub A
    Mol Nutr Food Res; 2016 Sep; 60(9):2008-19. PubMed ID: 27004411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.
    Taku K; Melby MK; Kurzer MS; Mizuno S; Watanabe S; Ishimi Y
    Bone; 2010 Aug; 47(2):413-23. PubMed ID: 20452475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
    Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
    Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.